Evidence map›Paper›PMID 40777144›Full record

ArticleFujita medical journal2025

Advanced machine learning models for prediction of readmission and mortality risks in patients with chronic obstructive pulmonary disease using routine clinical data.

Yasuhiro Goto, Daisuke Niwa, Shuhei Shibata, Ryoma Nishimoto, Masami Miyata, Takashi Kanno, Toshiyuki Washizawa, Masashi Kondo, Kazuyoshi Imaizumi

Abstract read
In one paragraph

Article in Fujita medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yasuhiro GotoDepartment of Respiratory Medicine, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Daisuke NiwaHome Healthcare New Business Planning Department, Teijin Pharma Limited, Chiyoda-ku, Tokyo, Japan.
Shuhei ShibataGlobal Business Services, IBM Japan, Ltd., Chuo-ku, Tokyo, Japan.
Ryoma NishimotoGlobal Business Services, IBM Japan, Ltd., Chuo-ku, Tokyo, Japan.
Masami MiyataDevelopment Office for Genomic Medical Research Center, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Takashi KannoHome Healthcare New Business Planning Department, Teijin Pharma Limited, Chiyoda-ku, Tokyo, Japan.
Toshiyuki WashizawaGlobal Business Services, IBM Japan, Ltd., Chuo-ku, Tokyo, Japan.
Masashi KondoDepartment of Respiratory Medicine, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Kazuyoshi ImaizumiDepartment of Respiratory Medicine, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To develop a comprehensive machine learning model incorporating various clinical factors, including frailty and comorbidities, to predict 30-day readmission and mortality risk in patients with chronic obstructive pulmonary disease (COPD). Methods: This retrospective cohort study used electronic health records (EHR) from Fujita Health University Hospital (2004-2019) for 1294 patients with COPD and 3499 hospitalization or death events. The EHR contained longitudinal patient data (demographics, diagnoses, test results, clinical records). We developed two eXtreme Gradient Boosting models, the comprehensive Top64 and practical 11-feature models. We compared these with the Comorbidity, Obstruction, Dyspnea, and Previous Exacerbations index (CODEX) model, a widely used tool for predicting hospital readmission or death in patients with COPD. The area under the receiver operating characteristic curve (AUC) with 95% confidence interval (CI), sensitivity, and specificity were used to evaluate the model performance. Results: The Top64 (AUC: 0.769, 95% CI: 0.747-0.791) and practical 11-feature (AUC: 0.746, 95% CI: 0.730-0.762) models performed better than the CODEX model (AUC: 0.587, 95% CI: 0.563-0.611). The Top64 model showed 0.978 sensitivity and 0.341 specificity, and the practical 11-feature model achieved 0.955 sensitivity and 0.361 specificity. The calibration curves showed good agreement between the observed and predicted results for both models. Conclusions: A machine learning approach based on clinical data readily available from the EHR performed better than existing models in predicting 30-day readmission and mortality risks in patients with COPD. A comprehensive risk prediction tool may enhance individualized care strategies and improve patient outcomes in COPD management.

Indexed as

Chronic obstructive pulmonary diseaseElectronic health recordsHospital readmissionMachine learningRisk prediction

Identifiers

PMID40777144
PMCPMC12327213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.